Skip to main content
PACOX logo

T. Rowe Price U.S. Equity Research Fund (PACOX) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$76.25 +$0.62 (+0.82%)

Beta 1.00: the stock has moved roughly in step with the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

T. Rowe Price U.S. Equity Research Fund (PACOX) trades at $76.25. T. Rowe Price U.S. Equity Research Fund (PACOX) aims to mirror the S&P 500 Index by investing in a diverse range of U.S. equities. Sector: Financials.

Price as of · Last analyzed: Mar 17, 2026
T. Rowe Price U.S. Equity Research Fund (PACOX) aims to mirror the S&P 500 Index by investing in a diverse range of U.S. equities. The fund's strategy involves maintaining sector and industry weights similar to the S&P 500, with potential exposure to small- and mid-cap stocks and foreign markets.

Analyst Coverage for PACOX: PACOX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the PACOX film Every key number, told as a short cinematic story — just press play. ~2 min

T. Rowe Price U.S. Equity Research Fund (PACOX) Financial Services Profile

HeadquartersBaltimore, US
IPO Year2004

T. Rowe Price U.S. Equity Research Fund (PACOX) offers investors exposure to a diversified portfolio of U.S. equities, mirroring the S&P 500's sector and industry allocations. The fund provides a benchmark-aware investment approach, with potential for small- and mid-cap and international exposure, operating within the competitive asset management landscape.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for PACOX?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

PACOX offers a benchmark-aware investment approach, seeking to mirror the S&P 500's performance. The fund's primary value driver is its ability to provide diversified exposure to the U.S. equity market. A potential catalyst is increased investor demand for passive investment strategies. The fund's performance is closely tied to the overall performance of the S&P 500, making it susceptible to market downturns. With a beta of 1.00, PACOX's volatility is expected to align with the market. The absence of a dividend yield may deter income-seeking investors. The fund's success hinges on maintaining accurate benchmark replication and managing expenses effectively.

Based on FMP financials and quantitative analysis

PACOX Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $1.67 billion, indicating a substantial asset base.

  • Beta of 1.00, suggesting the fund's volatility is expected to mirror the overall market.
  • Investment strategy focused on mirroring the S&P 500 Index, providing diversified exposure to U.S. equities.
  • Flexibility to invest in small- and mid-capitalization stocks and foreign equities, potentially enhancing returns.
  • Absence of dividend yield, which may be a consideration for income-focused investors.

Who Are PACOX's Competitors?

PACOX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AEDMX American Century Emerging Markets Fund $19.47 +1.09% $2.09B —
CSMVX Congress Small Cap Growth Fund $47.53 +1.39% $2.10B —
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund $14.94 -0.07% $1.74B —
FAMWX FAM Value Fund $107.57 +0.38% $1.79B —
GRMIX Nationwide S&P 500 Index Fund $34.84 +0.72% $1.83B —
BLK BlackRock, Inc. $1059.63 -0.44% $164B 49 5-pillar
BX Blackstone Inc. $111.74 -0.45% $135B 67 5-pillar
APOS Apollo Global Management, Inc. $25.59 -0.23% $74.8B 55 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PACOX's Key Strengths?

Strong brand recognition and reputation of T. Rowe Price.

  • Disciplined investment process focused on mirroring the S&P 500.
  • Diversified portfolio providing broad market exposure.
  • Relatively low expense ratio compared to actively managed funds.

What Are PACOX's Weaknesses?

Performance closely tied to the S&P 500, limiting potential for outperformance.

  • Lack of dividend yield may deter income-seeking investors.
  • Limited flexibility to deviate from the benchmark index.
  • Susceptible to market downturns and volatility.

What Are the Key Risks for PACOX?

Market downturns that negatively impact fund performance.

  • Increased competition from other index funds and ETFs.
  • Changes in investor sentiment towards passive investing.
  • Regulatory changes that impact the asset management industry.
  • Dependence on the performance of the S&P 500 Index.

What Are PACOX's Competitive Advantages?

  • Established brand name and reputation of T. Rowe Price.
  • Disciplined investment process focused on benchmark replication.
  • Low expense ratio compared to actively managed funds.
  • Diversified portfolio that mirrors the S&P 500 Index.

What Does PACOX Do?

T. Rowe Price U.S. Equity Research Fund (PACOX) is designed to replicate the investment profile of the Standard & Poor's 500 Stock Index (S&P 500 Index). The fund achieves this by weighting its investments across various sectors and industries in proportions that closely match those of the S&P 500. This approach aims to provide investors with returns that are similar to the overall performance of the U.S. equity market, as represented by the S&P 500. While the fund primarily focuses on large-capitalization U.S. common stocks, it also has the flexibility to invest in small- and mid-capitalization companies and, to a lesser extent, in foreign equities. This flexibility allows the fund to potentially enhance its returns or diversify its risk exposure. The fund's investment strategy is rooted in a disciplined portfolio construction process, emphasizing broad market representation and diversification. PACOX operates within the asset management industry, offering investors a passively managed investment vehicle that seeks to track the performance of a widely recognized market benchmark. The fund is managed by T. Rowe Price, a well-established investment management firm with a long history of providing investment solutions to individuals and institutions.

What Products and Services Does PACOX Offer?

  • Invests primarily in large-capitalization U.S. common stocks.
  • Weights sector and industry allocations to mirror the S&P 500 Index.
  • Provides exposure to small- and mid-capitalization stocks.
  • Offers limited exposure to foreign equities.
  • Seeks to replicate the performance of the S&P 500 Index.
  • Provides a diversified investment option for investors seeking broad market exposure.
  • Offers a passively managed investment strategy.

How Does PACOX Make Money?

  • Generates revenue through management fees charged on assets under management (AUM).
  • Aims to attract and retain investors by providing returns that closely track the S&P 500 Index.
  • Manages expenses to maintain a competitive expense ratio.
  • Distributes fund shares through various channels, including brokerage firms and financial advisors.

What Industry Does PACOX Operate In?

PACOX operates within the asset management industry, which is characterized by intense competition and evolving investor preferences. The industry is influenced by factors such as market volatility, interest rates, and regulatory changes. PACOX's strategy of mirroring the S&P 500 positions it as a passive investment option within a market increasingly favoring both passive and active strategies. Competitors include other index funds and actively managed equity funds. The asset management industry is experiencing growth in assets under management, driven by rising global wealth and increasing demand for investment solutions.

Who Are PACOX's Key Customers?

  • Individual investors seeking diversified exposure to the U.S. equity market.
  • Institutional investors, such as pension funds and endowments.
  • Financial advisors who recommend PACOX to their clients.
  • Retirement plan participants seeking a core equity holding.
Model self-rating on this text: 81% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is a fund, not an operating company

PACOX Financials

Bull Case vs Bear Case

Bull Case

  • Strong brand recognition and reputation of T. Rowe Price.
  • Disciplined investment process focused on mirroring the S&P 500.
  • Diversified portfolio providing broad market exposure.
  • Relatively low expense ratio compared to actively managed funds.

Bear Case

  • Performance closely tied to the S&P 500, limiting potential for outperformance.
  • Lack of dividend yield may deter income-seeking investors.
  • Limited flexibility to deviate from the benchmark index.
  • Susceptible to market downturns and volatility.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

PACOX Latest News

No recent news available for PACOX.

PACOX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for PACOX.

Price Targets

Wall Street price target analysis for PACOX.

PACOX MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for PACOX; grades run from A+ (80-100) to F (below 30).

What Investors Ask About T. Rowe Price U.S. Equity Research Fund (PACOX) — Financials

What does T. Rowe Price U.S. Equity Research Fund do?

T. Rowe Price U.S. Equity Research Fund (PACOX) is designed to mirror the performance of the S&P 500 Index. It invests primarily in large-cap U.S. equities, weighting its holdings to match the index's sector and industry allocations. This strategy offers investors a diversified, passively managed approach to gain exposure to the broad U.S. equity market.

What are the main risks for PACOX?

The primary risk for PACOX is its dependence on the performance of the S&P 500 Index. A market downturn or significant volatility in the U.S. equity market will directly impact the fund's returns. Additionally, competition from other index funds and ETFs could put pressure on its expense ratio.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data based on available information and may be subject to change.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis